hsa-miR-98

ncRNA information

ncRNA name

hsa-miR-98

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

ABCC10/MRP-7

Cancer information

Cancer name

Endometrial Cancer

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Paclitaxel

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Up

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

30

Male patients

30

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

downregulation of miR-98 have important roles in conferring paclitaxel resistance to EC cells

Tissue resource

fresh endometrial cancer samples and paired normal tissue samples

human endometrial cancer cell lines RL95

human endometrial cancer cell lines HEC-1

human normal endometrial fibroblast cell lines HESC

human normal endometrial fibroblast cell lines HEK293

Experiment

60


Institute

Hubei Cancer Hospital of Tongji Medical College of Huazhong University of Science and Technology

American Type Culture Collection

Country

China

United States

Continent

Asia

North Amercian